Notably, both control and tumor-treated SCs were able to alter gene expression in SCLC cells, although the effect of tumor-activated SCs on the expression of several genes, including STAT3, was significantly stronger than the effect of intact SCs. The gene discussed is STAT3; the disease is small cell lung carcinoma.